Introduction
As pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science market. This model will provide a forecast and analysis of IT spending in the pharma/biotech industries through 2013.
Reasons to Purchase
*Understand the opportunity size for technology spending in the global life science market
*Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies
*Segment the life science industry by spending opportunities
Other selected research from the 'IT & eHealth' category:
Maximizing eHealth Tools for Caregivers: Cultivating Long-Term Relationships
Caregivers are taking a more proactive role in providing healthcare to themselves and others, using online tools and services to find information, and influencing physician prescribing decisions by requesting particular medication or discussing specific products. By providing online resources for caregivers, pharma companies can increase brand loyalty among caregivers, and potentially, physicians. Learn More
Website Benchmarking Tool: European Healthcare Professional and Consumer Targeted Websites
The number of product information sites provided to consumers in the EU is limited, while disease and public education sites are abundant and are used to effectively target consumers, and sites targeting healthcare professionals in the EU are readily available. Sites must be optimized to of influence their target audiences, and to attract, convert and retain these important decision makers. Learn More